Option chain shows key data for Coeptis Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Coeptis Therapeutics.

Coeptis Therapeutics (NASDAQ:COEP) Stock, Option Chain

Coeptis Therapeutics

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

benzinga_deal_dispatch2

Asset Sales

Legal

AMPS

BABA

BIGGQ

COEP

CPNG

VIRX

Unlike Party City and Big Lots, The Container Store is staying in business. Plus, an oncology company searches for a deal.

Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues

Photo by solarseven on Shutterstock

Equities

News

Stock Split

Markets

Movers

General

Coeptis Therapeutics stock drops 22.5% after announcing a 1-for-20 reverse stock split to meet Nasdaq&#39;s listing requirements.





Why Is Coeptis Therapeutics Stock Falling On Friday?

cancer

Coeptis Therapeutics shares rise  after acquiring NexGenAI platform and launching Coeptis Technologies to enhance marketing in regulated industries.

Why Is Penny Stock Coeptis Therapeutics Gaining Today?

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Holdings, Inc. - Warrants

Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) has outperformed the market over the past 15 years by 5.77% on an annualized basis producing an average annual return of 17.46%. Currently, Centene has a market capitalization of $30.59 billion. 
Buying $100 In CNC: If an investor had bought $100 of CNC stock 15 years ago, it would be worth $1,117.05 today based on a price of $60.60 for CNC at the time of writing.
<h3>Centene's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735334113_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years

Management

VINC

Vincerx Implements Workforce Reduction Amid Strategic Streamlining; CEO Ahmed Hamdy Steps Down, Raquel Izumi Named Acting CEO, And Kevin Hass Takes Over As Acting CFO As Leadership Transitions Support Ongoing Strategic Efforts

<h3>Gainers</h3>
<ul>
<li>Ambow Education Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#AMEX">AMBO</a>) shares moved upwards by 38.4% to $3.1 during Friday's pre-market session. The company's market cap stands at $8.7 million. </li>
<li>Solid Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) shares increased by 37.89% to $2.69. The company's market cap stands at $485.0 million. </li>
<li>Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) stock rose 14.96% to $6.3. The market value of their outstanding shares is at $209.7 million. </li>
<li>Nxu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXU#NASDAQ">NXU</a>) stock increased by 13.2% to $0.3. The market value of their outstanding shares is at $4.6 million. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) stock increased by 13.16% to $0.49. The company's market cap stands at $31.7 million. </li>
<li>Premium Catering (Hldgs) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PC#NASDAQ">PC</a>) stock moved upwards by 12.99% to $0.82. The company's market cap stands at $13.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) stock declined by 11.6% to $0.46 during Friday's pre-market session. The market value of their outstanding shares is at $10.8 million. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) shares decreased by 8.14% to $0.34. The company's market cap stands at $1.5 million. </li>
<li>Mixed Martial Arts Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock fell 6.29% to $1.64. The company's market cap stands at $17.1 million. </li>
<li>JX Luxventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXG#NASDAQ">JXG</a>) stock declined by 5.92% to $0.89. The company's market cap stands at $5.3 million. </li>
<li>Global Business Travel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTG#NYSE">GBTG</a>) shares fell 5.86% to $9.0. The company's market cap stands at $4.2 billion. </li>
<li>Brilliant Earth Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLT#NASDAQ">BRLT</a>) stock fell 5.42% to $1.92. The market value of their outstanding shares is at $26.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

AMBO

BRLT

GBTG

LAZR

SLDP

XELB

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

Vincerx Pharma Announces Binding Term Sheet For Strategic Merger With Oqory, Inc.; Oqory Equity Holders To Own 95% Of Combined Entity, Vincerx 5%; Merger Includes $13.66M Equity Value For Vincerx Stockholders And $20M Equity Financing Requirement

<h3>Gainers</h3>
<ul>
<li>Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) stock moved upwards by 60.0% to $3.44 during Friday's pre-market session. The market value of their outstanding shares is at $605.0 million. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) shares increased by 39.47% to $1.18. The market value of their outstanding shares is at $6.9 million. </li>
<li>Serina Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SER#AMEX">SER</a>) stock moved upwards by 32.76% to $7.01. The company's market cap stands at $62.3 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) stock moved upwards by 25.42% to $1.48. The company's market cap stands at $60.0 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares rose 18.01% to $0.99. The market value of their outstanding shares is at $67.9 million. </li>
<li>Tiziana Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSA#NASDAQ">TLSA</a>) shares moved upwards by 14.35% to $0.8. The market value of their outstanding shares is at $83.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) stock declined by 20.8% to $8.4 during Friday's pre-market session. The market value of their outstanding shares is at $569.8 million. </li>
<li>Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) shares fell 11.83% to $29.0. The company's market cap stands at $157.6 million. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) stock declined by 11.45% to $4.95. The company's market cap stands at $5.5 million. </li>
<li>Viracta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRX#NASDAQ">VIRX</a>) stock declined by 10.38% to $0.21. The market value of their outstanding shares is at $8.4 million. </li>
<li>Procaps Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROC#NASDAQ">PROC</a>) shares decreased by 9.32% to $2.24. The company's market cap stands at $252.7 million. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) stock decreased by 8.42% to $0.29. The market value of their outstanding shares is at $6.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTCX

DHAI

EVAX

NUTX

PHAR

PROC

PRTG

TLSA

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares increased by 64.1% to $2.33 during Friday's pre-market session. The market value of their outstanding shares is at $833.2 million. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares rose 31.69% to $0.55. The company's market cap stands at $67.4 million. </li>
<li>Odyssey Marine Explr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) shares increased by 27.9% to $0.61. The company's market cap stands at $17.8 million. </li>
<li>Nauticus Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) shares moved upwards by 23.03% to $2.19. The market value of their outstanding shares is at $14.0 million. </li>
<li>CBAK Energy Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAT#NASDAQ">CBAT</a>) stock rose 22.73% to $1.12. The company's market cap stands at $100.7 million. </li>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) shares rose 21.53% to $3.16. The market value of their outstanding shares is at $43.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quest Resource Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRHC#NASDAQ">QRHC</a>) shares decreased by 19.0% to $5.02 during Friday's pre-market session. The market value of their outstanding shares is at $102.3 million. </li>
<li>Markforged Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>) shares declined by 8.03% to $2.98. The market value of their outstanding shares is at $61.4 million. </li>
<li>Gencor Industries (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GENC#AMEX">GENC</a>) stock declined by 7.4% to $16.85. The company's market cap stands at $247.0 million. </li>
<li>Mynaric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares declined by 6.95% to $0.43. The market value of their outstanding shares is at $10.8 million. </li>
<li>XCHG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) shares declined by 6.67% to $2.24. The market value of their outstanding shares is at $133.1 million. </li>
<li>Nocera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCRA#NASDAQ">NCRA</a>) shares decreased by 6.23% to $0.93. The company's market cap stands at $13.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CBAT

GENC

KITT

MKFG

MYNA

NCRA

OMEX

QRHC

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares increased by 359.9% to $2.07 during Friday's pre-market session. The market value of their outstanding shares is at $18.0 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) shares rose 112.08% to $8.95. The market value of their outstanding shares is at $11.2 million. </li>
<li>iLearningEngines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) stock rose 102.6% to $0.33. The market value of their outstanding shares is at $46.1 million. </li>
<li>T Stamp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) shares rose 50.0% to $0.81. The market value of their outstanding shares is at $20.4 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock moved upwards by 40.62% to $1.8. The market value of their outstanding shares is at $16.4 million. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) stock moved upwards by 21.61% to $1.24. The market value of their outstanding shares is at $116.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) stock fell 11.6% to $1.22 during Friday's pre-market session. The market value of their outstanding shares is at $68.4 million. </li>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) stock fell 9.22% to $3.25. The market value of their outstanding shares is at $149.0 million. </li>
<li>Sigmatron Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) stock fell 8.34% to $1.54. The market value of their outstanding shares is at $9.4 million. </li>
<li>Silvaco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVCO#NASDAQ">SVCO</a>) shares fell 7.69% to $7.57. The company's market cap stands at $215.4 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) stock fell 5.97% to $2.68. The company's market cap stands at $26.7 million. </li>
<li>Saiheat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIH#NASDAQ">SAIH</a>) shares declined by 5.65% to $0.7. The market value of their outstanding shares is at $17.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AILE

AIRE

IDAI

INTZ

LIDR

MLGO

MYSZ

REKR

SAIH

SGMA

SVCO

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Earnings

CCTG

CCSC Technology International H1 2025 Revenue $9.2M Vs $7.5M YoY; EPS $(0.06) Vs $(0.04) YoY

WIIM

CCSC Technology International Holdings shares are trading higher after the company reported financial results for the first six months of FY25.

Trading Halt: Halted at 4:01:00 p.m. ET - Trading Halt: Halt News Pending

Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) has outperformed the market over the past 20 years by 2.91% on an annualized basis producing an average annual return of 11.28%. Currently, Autodesk has a market capitalization of $63.99 billion. 
Buying $1000 In ADSK: If an investor had bought $1000 of ADSK stock 20 years ago, it would be worth $7,932.54 today based on a price of $296.92 for ADSK at the time of writing.
<h3>Autodesk's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735332959_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADSK

Here's How Much $1000 Invested In Autodesk 20 Years Ago Would Be Worth Today

The S&amp;P 500 index is set to end 2024 with its strongest edge over global equities in nearly 30 years, a remarkable streak fueled <a href="https://www.benzinga.com/news/econ-s">by U.S. economic dominance. </a>
Yet, Bank of America analysts caution that the rally's days may be numbered, predicting a reversal as early as the second quarter of 2025.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) has surged 25% year-to-date as of Dec. 27, delivering a 21-percentage-point edge over global equities excluding U.S. exposure, tracked by the iShares MSCI ACWI ex U.S. ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACWX#NYSE">ACWX</a>)
That marks the widest outperformance of American versus world equities since 1997. 
This is also the widest performance gap since 1997, driven by investor positioning for &#8220;Trump trades&#8221; of higher U.S. dollar, equities and bond yields, according to Bank of America&#8217;s chief investment strategist Michael Hartnett.
Hartnett predicts that an &#8220;inflation boom&#8221; in the U.S. combined with a &#8220;global deflation bust&#8221; will drive a first-quarter overshoot in U.S. stocks. 
&#8220;We believe US small cap&nbsp;(Russell 2000)&nbsp;is the&nbsp;best trade to&nbsp;position for&nbsp;overshoots,&#8221; Hartnett said in a recent report. 
Hartnett highlighted that global equity markets are heading into 2025 with significantly weak economic momentum, especially in manufacturing &#8211; and this is even before factoring in the potential impact of a trade war.
But, as the champagne flows this New Year's Eve, Bank of America analysis suggests a sobering reality may await from the second quarter of 2025.
<h3 class="wp-block-heading">Chart: S&amp;P 500 Sharply Outperformed International Equities In 2024</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="557" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-1024x557.png" alt="" class="wp-image-709750" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-1024x557.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-768x418.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-1536x835.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">A Shift To International Markets?</h3>
By spring 2025, Bank of America forecasts a hawkish Federal Reserve and &#8220;policy panic&#8221; in Europe and Asia to trigger a peak in U.S. market &#8220;exceptionalism.&#8221; 
According to Hartnett a strong U.S. dollar, already near multi-year highs, contributed to U.S. stocks' outperformance but poses risks given that 30% of S&amp;P 500 revenues come from overseas markets.
Hartnett projects that aggressive fiscal easing in China, new European stimulus – boosted by potential German election outcomes – and rate cuts by the European Central Bank will create fertile ground for global equities.
This could lead to significant rotations into international equities and currencies. 
"By Q2, we anticipate lower interest rates, cheaper currencies, and fiscal easing in Europe and China," Hartnett said.
Emerging markets, battered by a strong dollar and trade uncertainty, may finally rebound as the greenback loses steam.
David Hauner, head of global emerging markets fixed income strategy at Bank Of America, remains cautious on emerging markets in the near term but sees buying opportunities as U.S. trade policies become clearer and the dollar reaches a turning point.
<h3 class="wp-block-heading">2025: Volatility And Opportunity</h3>
Savita Subramanian, Bank of America&#8217;s head of U.S. equity strategy, said potential Trump 2.0 policies could heighten inflation and deficit risks.
&#8220;Trump 2.0 may drive higher uncertainty around inflation and deficit risks.&nbsp;Immigration and tariffs may be inflationary, but corporate tax cuts are disinflationary as benefits get passed onto the consumer,&#8221; Subramanian said.
She highlighted the prospects for a strong GDP upcycle, driven by lighter regulations and increased energy production lowering oil prices.
Despite predictions of volatility return in 2025, Bank of America analysts remain bullish on the S&amp;P 500. 
They indicated an ambitious year-end target of 6,666 for 2025, marking a staggering 10x rally from the market's 2009 lows.
"Volatility will present opportunities to buy the S&amp;P 500 at lower levels in 2025," said Subramanian, adding that the index is likely to close the year higher than current levels.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/12/42701155/made-in-china-paid-in-america-what-trumps-new-tariffs-mean-for-the-us-economy">Made In China, Paid In America: What Trump&#8217;s New Tariffs Mean For The US Economy</a></li>
</ul>
Photo: Shutterstock

Guidance

Eurozone

Economics

Analyst Ratings

ACWX

S&P 500 Poised For Best Year Vs. Global Stocks Since 1997: Bank Of America Warns Of 2005 Rotation

GDS Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) are trading higher Friday amid continued interest sparked by reports that the company is evaluating an initial public offering (IPO) for its<a href="https://www.benzinga.com/quote/GDS/news"> data center assets in China.</a>
What To Know: Sources familiar with the matter, who requested anonymity due to the private nature of the discussions, indicated that GDS is collaborating with advisers to gauge investor interest in the potential IPO, <a href="https://www.bloomberg.com/news/articles/2024-12-24/data-center-operator-gds-is-said-to-consider-ipo-of-china-reit">according to Bloomberg.</a> 
The proposed real estate investment trust (REIT) could generate proceeds of approximately 1 billion yuan, equivalent to about $140 million. However, the deliberations are still in preliminary stages and the possibility remains that no final transaction will occur. The company has not provided any official comment on the matter.
Over the past year, the Chinese government has relaxed rules regarding the eligibility of assets for inclusion in REITs, a move that analysts believe could establish China as a significant player in the global commercial property trust market. Since these regulatory changes, 13 REIT IPOs have been priced in China. Furthermore, the China Securities Regulatory Commission is reportedly working on incorporating REITs into the Hong Kong Stock Connect program, a move designed to increase exposure to offshore investors.
The company also announced a $1.2 billion Series B funding round for its international data centers. Notable participants in this round included Coatue Management, SoftBank Vision Fund and Ken Griffin, CEO of Citadel. This funding underscores GDS's broader strategy to position itself as a major player in the global data center space while leveraging favorable developments in the REIT market domestically.
GDS Price Action: GDS Holdings shares were up 7.38% at $22.18 at publication Friday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="511" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-1024x511.png" alt="" class="wp-image-709691" style="width:528px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-1024x511.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-1536x767.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25.png 1538w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/24/12/42709387/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a></li>
</ul>
Photo: Shutterstock.

REIT

Global

Real Estate

GDS Holdings Shares Are Up Today: What You Need To Know

In the current session, Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) is trading at $447.22, after a 0.65% decrease. Over the past month, the stock decreased by 13.71%, and in the past year, by 23.25%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1735332319_0.png" alt="Past Year Chart" />

<h3>Adobe P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 96.7 in the Software industry, Adobe Inc. has a lower P/E ratio of 36.42. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1735332319_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

ADBE

P/E Ratio Insights for Adobe

<h2 class="wp-block-heading">Bankruptcy Block</h2>
Party City Holdco Inc., the one-stop-shop for all things celebration, is calling it a wrap. The company&#8217;s 700 stores are holding going-out-of-business sales. 
This is the second time Party City filed for Chapter 11 bankruptcy protection in two years. In 2023, a restructuring process eliminated almost $1 billion in debt — not enough to keep the party going.
Party City also faced some serious buzzkills like inflation and, per a New York Post <a href="https://nypost.com/2023/01/25/party-citys-founder-blames-bankruptcy-on-private-equity-firms/">interview</a> with the chain&#8217;s founder, Steve Mandell, shoddy leadership.
Party City is owned by investment firms such as Capital Group, Davidson Kempner and Silver Point Capital.
The Woodcliff Lake, New Jersey-based company filed for Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
Over 95% of Party City's 12,000 employees will stay on until <a href="https://www.cnn.com/2024/12/20/business/party-city-shut-down/index.html">Feb. 28</a> to help with the big cleanup.
The news of Party City&#8217;s demise came just days after bankrupt retailer Big Lots (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BIGGQ#OTC">BIGGQ</a>) <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42624759/big-lots-holds-liquidation-sales-analyst-pegs-competitor-as-major-beneficiary-market-share-capture-opportunity">failed to find a buyer</a>.
The retailer previously announced it was selling its assets to private equity firm Nexus Capital Management back in September. But now the deal is pretty much off the table.
In true clearance-sale spirit, the company is launching its "going out of business" blowout. It's also keeping hope alive by exploring other options. Whether that's cajoling Nexus back to the table or finding a new buyer remains to be seen. 
That&#8217;s not all. <a href="https://www.benzinga.com/news/asset-sales/24/11/42254293/deal-dispatch-stoli-bankrupt-ally-financial-to-sell-credit-card-unit">Benzinga Deal Dispatch reported</a> last month The Container Store was on the verge of bankruptcy. Recall how it was unable <a href="https://www.benzinga.com/markets/equities/24/10/41356027/whats-going-on-with-container-store-stock-after-getting-40m-investment-from-beyond">to ink a deal</a> with Beyond Inc. The <a href="https://www.businesswire.com/news/home/20241222725949/en/The-Container-Store-to-Execute-Comprehensive-Recapitalization-Transaction-with-Lender-Support-to-Best-Position-the-Company-for-Future-Success">filing</a> became official on Sunday, Dec. 22, in a Texas district court.
But unlike Party City and Big Lots, The Container Store is staying in business.
&#8220;Our strategy is sound,&#8221; said The Container Store CEO Satish Malhotra. 
The beloved storage solutions and in-home services provider is tidying up its finances. Up to 90% of the company's term loan lenders have jumped on board with a transaction support agreement. 
The Container Store will have $40 million in fresh funds and $45 million in debt reduction. All this means The Container Store is aiming keep its promises to partners, vendors and stakeholders without a hitch. 
The company expects to exit bankruptcy within the next 30 days. When it re-emerges, it will be a private company.
The Container Store&#8217;s Elfa business in Sweden remains unaffected. 
See Also: <a href="https://www.benzinga.com/24/12/42710061/cannabis-reform-2024-the-year-of-all-talk-and-no-action">Cannabis Reform 2024 — The Year Of All Talk And No Action</a>
<h2 class="wp-block-heading">New On The Block</h2>
Viracta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRX#NASDAQ">VIRX</a>) is considering a sale. The oncology company — focused on virus-associated cancers — announced the process as part of a strategic review. Viracta voluntarily closed its pivotal Phase 2 NAVAL-1 trial of Nana-val for relapsed/refractory EBV+ lymphomas, citing no new safety concerns. CEO Mark Rothera remains optimistic about Nana-val&#8217;s future approval. 
<h2 class="wp-block-heading">Updates From The Block</h2>
Buyout firm TPG is in talks to acquire Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>), a solar energy provider to commercial property owners and residential homes, Reuters reported on Dec. 23. A competing bid could emerge. 
Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)&nbsp;<a href="https://www.benzinga.com/news/24/12/42680655/alibaba-nears-4b-e-commerce-merger-with-south-koreas-e-mart-report">is close to merging</a>&nbsp;its South Korean operations with&nbsp;E-Mart Inc.&nbsp;in a deal valued at approximately $4 billion. This strategic move aims to bolster their position in South Korea&#8217;s competitive online retail market. The potential joint venture would combine the e-commerce assets of both companies. Discussions are ongoing, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-12-26/alibaba-is-said-to-near-4-billion-deal-with-korea-s-e-mart">reported</a>&nbsp;on Thursday.
<h2 class="wp-block-heading">Notes From The Block</h2>
In 2024, private equity and financial investors showed renewed interest, according to Bain &amp; Co. Deal value increased by 29% year-over-year due to <a href="https://www.benzinga.com/topic/interest-rates">slightly lower interest rates</a>.
Corporate M&amp;A, less impacted by minor debt cost changes, is projected to finish the year 12% higher than 2023, with a 7% rise in deal volume across all regions, the firm noted.
&#8220;Overall, the level of M&amp;A activity was a middling $3.5 trillion,&#8221; the firm <a href="https://www.bain.com/insights/looking-back-m-and-a-report-2025/">noted</a>. &#8220;That&#8217;s a number consistent with what we saw in the mid-2010s.&#8221;
For last week&#8217;s <a href="https://www.benzinga.com/news/rumors/24/12/42635878/deal-dispatch-honeywell-textron-soho-house-m-and-a-moves">Deal Dispatch, click here</a>. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42701686/bitcoin-could-slide-to-60000-technical-analyst-warns">Bitcoin Could Slide To $60,000, Technical Analyst Warns</a></li>
</ul>

Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares are trading higher on Friday, possibly following the company&#8217;s announcement of a 1-for-10 <a href="https://www.benzinga.com/pressreleases/24/12/n42669127/siyata-announces-reverse-stock-split">reverse stock split on Tuesday.</a>
What To Know: The move is aimed at maintaining compliance with Nasdaq&#8217;s $1 minimum bid price requirement. The reverse stock split will be effective on Dec. 27, 2024, with trading on a post-split basis commencing the same day under the ticker symbol &#8220;SYTA.&#8221;
The reverse stock split consolidates every 10 existing shares into one new share. Outstanding stock options, warrants and other convertible securities will also be adjusted to reflect the new ratio. No fractional shares will be issued, with fractions rounded up to the nearest whole number.
Siyata, a global provider of Push-to-Talk over Cellular devices and cellular signal boosters, clarified that the split does not affect the par value or authorized number of shares. The transfer agent, Computershare, will handle the exchange process for registered shareholders. Those holding shares electronically or through brokers will have their positions adjusted automatically.
Despite the stock price jump, the company warned there is no guarantee it will maintain compliance with the minimum bid price requirement after the split.
SYTA Price Action: Siyata Mobile shares were up 23.62% at $6.43 at publication Friday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="530" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08-1024x530.png" alt="" class="wp-image-709735" style="width:463px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08-1024x530.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08-768x398.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08.png 1528w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42709939/apple-teases-streaming-see-for-yourself-event-could-this-be-a-free-preview-of-appletv-or-ad-supported-platform"> Apple Teases Streaming &#8216;See For Yourself&#8217; Event: Could This Be A Free Preview Of AppleTV+ Or Ad-Supported Platform?</a></li>
</ul>
Photo: Shutterstock

SYTA

Siyata Mobile Shares Are On The Rise Friday: What's Going On?

After a surge in betting on prediction markets for outcomes of events like the 2024 U.S. presidential election, the next market that is generating plenty of interest and concern from regulators is the outcome of the murder<a href="https://www.benzinga.com/24/12/42541669/luigi-mangione-faces-murder-first-degree-life-in-prison-in-ceo-death-a-senseless-act-of-violence"> trial of Luigi Mangione.</a>
What Happened: Mangione <a href="https://www.benzinga.com/24/12/42655562/luigi-mangione-suspected-ceo-assassin-pleads-not-guilty-in-new-york-court">recently pleaded not guilty</a> to New York state charges that include murder in the first degree of UnitedHealthcare CEO Brian Thompson.
Recently extradited from Pennsylvania to New York, Mangione also faces federal charges that could lead to a death penalty sentence if he is found guilty.
Mangione&#8217;s story has captured plenty of attention in America as evidence linked the killing of Thompson, who was CEO of the insurance company owned by UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), to Mangione allegedly<a href="https://www.benzinga.com/24/12/42605759/luigi-mangione-faces-death-penalty-details-show-attack-planned-for-months-the-target-is-insuranceit-checks-every-box"> targeting the health insurance sector</a> that he viewed as putting greed ahead of consumer health.
Ahead of Mangione's extradition and court hearings, people in the U.S. and around the world have been able to bet on the outcomes thanks to the rise of prediction markets.
Kalshi, which is regulated by the Commodity Futures Trading Commission, took wagers on several items beginning on Nov. 11 and bragged about the numerous markets on social media platform X.
Among the Kalshi markets: whether Mangione would be extradited, whether he would plead guilty, if he would be convicted, if he or a family member had insurance with UnitedHealthcare and whether he acted alone in the alleged murder of Thompson.
Kalshi <a href="https://kalshi.com/markets/kxuhcplea/luigi-guilty-plea">halted </a>the Mangione markets, but they can still be found on the website through a search. The markets are listed as "paused." Kalshi has put the blame for the halt in the hands of regulators, according to a report from <a href="https://www.bloomberg.com/news/articles/2024-12-27/bets-on-ceo-murder-suspect-s-fate-test-rules-on-event-contracts?sref=TBDibEcD">Bloomberg</a>.
The CFTC bans futures trading for war, terrorism and crimes like assassinations, according to the report.
Prediction market Polymarket has multiple <a href="https://polymarket.com/markets?_q=luigi+mangione">markets </a>open connected to the Mangione case, including whether a YouTube channel connected to him is real, if he was a lone actor, if he will fire his lawyer, whether his parents were UnitedHealthcare customers and if he used psychedelics.
Polymarket is not regulated in the United States. On Polymarket, users can deposit funds using USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) via the Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>) network or can deposit directly from a crypto account with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>).
BetUS, which is regulated in certain territories, is <a href="https://press.betus.com.pa/245601-betus-offers-odds-on-the-luigi-mangione-case">offering </a>betting odds on several Mangione-related outcomes like whether he will plead guilty before May 31, 2025. The betting odds are set at -350 for No and +225 for Yes. BetUS also said it will offer lines on whether Mangione used psychedelics and if he will fire his lawyer in 2025.
Read Also: <a href="https://www.benzinga.com/news/legal/24/12/42418763/unitedhealthcare-ceo-murder-suspect-chronic-pain-unabomber-fascination-isolation-details-emerge">UnitedHealthcare CEO Murder Suspect: Chronic Pain, Unabomber Fascination, Isolation Details Emerge</a>
Why It's Important: Mangione's case has led to plenty of support from the public due to hatred for the health insurance industry by some, an item<a href="https://www.benzinga.com/media/24/12/42473433/joe-rogan-on-public-sympathy-for-unitedhealthcare-ceo-murder-suspect-health-insurance-a-dirty-dirty-business"> touched on by</a> popular podcaster Joe Rogan. 
Supporters have shown up outside courtrooms with signs backing the alleged murderer. The mention of Mangione on a recent episode of "Saturday Night Live" led members of the audience to cheer at his name.
Prediction markets have risen in popularity thanks to the 2024 election and are able to offer markets quickly on a variety of topics and viral news stories.
When it comes to murder cases, there will likely be push back from regulators and members of the public who see a moral obligation to avoid profiting from bad actors. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42544499/luigi-mangione-documentaries-in-the-works-from-award-winning-creators-and-possibly-rapper-50-cent">Luigi Mangione Documentaries In The Works From Award-Winning Creators — And Possibly Rapper 50 Cent</a></li>
</ul>
Luigi Mangione photo courtesy of Pennsylvania State Police.

Government

Regulations

$ETH

$MATIC

$USDC

Can You Bet On Luigi Mangione's Fate? Betting Platforms, Regulators Wrestle With Limits In Growing Market

Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) has outperformed the market over the past 10 years by 16.33% on an annualized basis producing an average annual return of 27.52%. Currently, Synopsys has a market capitalization of $76.25 billion. 
Buying $1000 In SNPS: If an investor had bought $1000 of SNPS stock 10 years ago, it would be worth $11,277.82 today based on a price of $493.26 for SNPS at the time of writing.
<h3>Synopsys's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735331714_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SNPS

Here's How Much You Would Have Made Owning Synopsys Stock In The Last 10 Years

The end of the holiday week encountered volatility, with the major U.S. indices <a href="https://www.benzinga.com/24/12/42706638/dow-dips-over-500-points-us-goods-trade-deficit-widens-in-november">suffering conspicuous declines</a>. In turn, the cryptocurrency ecosystem was muted, extending a soft spell that began around a week-and-a-half ago. Unfortunately for investors of crypto miners like MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), the downturn also impacted the business end of the blockchain. However, contrary to popular belief, speculators should consider refraining from buying the dip.
Of course, the temptation is understandable. At the beginning of this week, Benzinga's <a href="https://www.benzinga.com/insights/options/24/12/42659841/smart-money-is-betting-big-in-mara-options">unusual options activity</a> screener identified a substantial volume of bearish activity against MARA stock. Specifically, the biggest transaction among the whales — or institutional investors — was for $8 put options expiring Jan. 16, 2026. That implies about a 57% implosion from the time-of-writing price.
Still, as the <a href="https://www.benzinga.com/top-stories/24/07/39699599/benzinga-founder-jason-raznick-on-meme-stocks-importance-of-diversification-didnt-want-to-lose-a-gen">meme-stock phenomenon</a> demonstrated, contrarian speculation can sometimes lead to big rewards. Fueling this sentiment is the fact that, at the moment, MARA stock represents one of the <a href="https://www.benzinga.com/short-interest/largest-increase">largest increases in short interest</a>. Currently, MARA's short interest stands at 25.12%, whereas the prior reading sat at 20.98%.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27143044/MARA-stock-12272024-1024x598.jpg" alt="" class="wp-image-709694" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27143044/MARA-stock-12272024-1024x598.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27143044/MARA-stock-12272024-300x175.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27143044/MARA-stock-12272024-768x448.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27143044/MARA-stock-12272024.jpg 1031w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
By aggressively piling into the long side, the contrarian bulls could theoretically panic out the bears. Structurally, in order to close out a short position, the bearish trader must execute a counterbalancing long transaction. Logically, a panicked rush of long volume could skyrocket the target security, leading to a bonanza.
Nevertheless, the empirical data doesn't support this approach for MARA stock.
Also Read: <a href="https://www.benzinga.com/general/biotech/24/12/42710358/veteran-investor-bets-big-on-sp-500-hitting-7000-by-end-of-2025-these-sectors-could-lead-the-charge">Veteran Investor Bets Big On S&amp;P 500 Hitting 7,000 By End Of 2025: These Sectors Could Lead The Charge</a>
<h2 class="wp-block-heading">Dynamic Probability Analysis Reveals a Surprising Outcome</h2>
In baseball, knowing a player's batting average over the past few seasons is only partially useful. What's more beneficial to managers is understanding a player's tendencies in key situations, such as the batting average when there are runners in scoring position. Great athletes naturally rise to the occasion and this philosophy applies to Wall Street as well.
Over the past five years, the likelihood that any given week will end in a positive return comes out to 50.2%. This figure is calculated by taking the number of positive weeks over the total number of weeks in the given dataset (i.e. trailing five years). However, this simple frequentist calculation doesn't reveal much, similar to the utility of a batting average over a full season.
Instead, it's better to apply a dynamic probability analysis by understanding how MARA stock responds to extreme volatility. As of this writing, MARA is on pace to record a five-day loss of around 7%. Using this metric as the "anchor," an investor can calculate how such a volatile event impacts the probability of the following week.
In the blockchain miner's case, over the past five years, there have been 89 instances when MARA stock incurred a 7% loss or worse. Of this tally, 44 subsequent weeks recorded a positive return or a success ratio of 49.44%. Practically speaking, aberrant volatility offers no reliable indicator beyond a coin toss as to whether or not MARA will immediately rise.
However, when the blockchain miner offers a positive response week, the average return comes out to 18.2%. On the flipside, a negative response week yields an average loss of 13.2%. By extracting this critical intelligence, traders can make an informed decision about a potentially appropriate options strategy.
<h2 class="wp-block-heading">A Long Iron Condor Trade Beckons for MARA Stock</h2>
Although the immediate direction of MARA stock is not statistically clear, the empirical data reveals that there is a good chance of significant mobility. Therefore, investors may consider a directionally neutral strategy called the long iron condor.
Structurally a combination of a <a href="https://www.benzinga.com/money/bull-spread">bull call spread</a> and a <a href="https://help.benzinga.com/en/articles/6332560-bear-put-spread-options-trade">bear put spread</a>, the central idea is that the participating trader anticipates unusual kinesis in either direction. Of the four legs of the long iron condor, the trader is betting that the target security can rise to the uppermost strike price (or the bull call spread's short strike) or fall to the lowermost strike price (or the bear put spread's short strike).
For the unaccustomed trader, picking a long iron condor is a frustrating guessing game. However, thanks to the aforementioned dynamic probability analysis, investors can apply data-driven intelligence to their transactions. Specifically, integrating the average upside and downside (assuming a weekly 7% loss) to the current share price reveals a projected range between $16.08 and $21.89 by the end of the following week.
From here, it's about finding the best fit within the broader context of the trader's risk tolerance. For instance, an investor could find a long iron condor expiring next Friday (Jan. 3) where the lowermost and uppermost strike prices are $16 and $22, respectively. However, there's no guarantee that MARA will hit these figures; the aforementioned calculations are based on probabilities, not certainties.
For a slightly more conservative trade, one might consider the 17P &#x7C; 18P &#x7C;&#x7C; 20C &#x7C; 21C condor or the 17/18 bear put spread combined with the 20/21 bull call spread. To receive the maximum payout, MARA stock needs to rise to $21 or fall to $17. While still risky, it's a comparatively more realistic trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42707484/exxonmobil-stock-navigates-death-cross-market-signals-turn-bearish-for-the-oil-giant">ExxonMobil Stock Navigates Death Cross: Market Signals Turn Bearish For Oil Giant</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Options

MARA

Options Corner: MARA Holdings' Wild Swings Incentivizes A Directionally Neutral Iron Condor Trade

RYDE

Ryde Group shares are trading higher after the company on Thursday announced it renewed its 3-year ride-hail and carpool licenses in Singapore.

Warning: COEP is at high risk of performing badly

Coeptis Therapeutics (COEP) announced the execution of a Binding Letter of Intent for the acquisition of NexGenAI Affiliates Network, a platform de...

Coeptis Therapeutics to acquire NexGenAI Affiliates Network

Coeptis Therapeutics (COEP) announced it will proceed with a 1-for-20 reverse stock split of its issued and outstanding shares of common stock, fol...

Coeptis Therapeutics announces 1-for-20 reverse stock split

Coeptis Therapeutics announces reverse stock split

Screenshot 2024-02-29 at 7.16.11 PM

Biotech

ATNM

Here&#39;s How Coeptis Therapeutics Is Innovating Cell Therapy Approaches

Press Releases

Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering

Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders

Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy

Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use

Small Cap

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies

Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies

Coeptis Therapeutics Announces Reverse Stock Split

ABVC BioPharma

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Ainos

Aptevo Therapeutics

BioCardia

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Galecto

Genprex

GRI Bio

GT Biopharma

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Mustang Bio

Mainz Biomed

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Polyrizon

PharmaCyte Biotech

Soligenix

Turnstone Biologics

T2 Biosystems

Viracta Therapeutics, Inc. - Common Stock

Viracta Therapeutics

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Ladenburg Thalmann

EF Hutton

JonesTrading

Coeptis Therapeutics shares are trading lower after the company announced a 1-for-20 reverse stock split.

Comments

Coeptis Therapeutics

Coeptis Therapeutics (COEP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga